Piramal Pharma Ltd

Growth Ratio Summary

Growth Score : 8.00

Growth ratios suggest strong positive momentum, particularly in operating profit, EPS, asset growth, and net income. However, this is counterbalanced by Revenue growth rate. This indicates strong potential for future expansion and profitability. Strategic investments and market positioning may further enhance growth prospects.

Financial Ratio Summary

Financial Score : 4.00

Financial ratios reflect mixed performance. While capital expenditures are well-managed, Adjusted EPS, Cash EPS, Book Value Per Share, and DPS indicate areas needing improvement. This suggests potential challenges in earnings quality and shareholder returns. Strategic financial management is essential to optimize these metrics.

Profitability Ratio Summary

Profitability Score : 6.20

Profitability ratios indicate a mixed performance. Strong returns on capital employed, equity, and assets are offset by Gross profit margin, Operating margin and Net Margin. Improving these margins would enhance overall profitability. The weighted average calculation underscores the need for a comprehensive approach to profitability management.

Efficiency Ratio Summary

Efficiency Score : 4.67

Efficiency ratios suggest some operational challenges in asset utilization. While days sales in inventory and receivable days are well managed, turnover ratios for fixed assets, inventory, receivables, and capital indicate potential inefficiencies. Optimizing these turnover rates can improve overall performance. The weighted average calculation highlights the need for a balanced approach to asset management.

Coverage Ratio Summary

Coverage Score : 6.80

Coverage ratios suggest an average capacity to meet interest and dividend obligations. While interest coverage is adequate, equity dividend coverage indicates room for improvement. Strengthening these ratios would enhance financial security and investor confidence. The weighted average calculation reflects a moderate ability to handle financial obligations.

Solvency Ratio Summary

Solvency Score : 10.00

The company's solvency is strong, indicating a solid long-term financial stability. A high Equity Ratio and low Debt ratios reflect a conservative capital structure, reducing financial risk. This provides a stable foundation for future growth and operational flexibility. This suggests that the company is well-positioned to manage its long-term debt obligations.

Liquidity Ratio Summary

Liquidity Score : 2.00

The liquidity position is weak, suggesting potential difficulties in meeting short-term obligations. This could hinder operational flexibility and increase financial risk. While the healthcare industry can have unique working capital dynamics, maintaining adequate liquidity is crucial for managing day-to-day expenses and unexpected needs. The weighted average calculation considers the past five years, highlighting a consistent challenge.